HF COMPANY |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.48 EUR | -1.08% |
|
-4.53% | +1.86% |
| 20/02 | Stef: SPFA crosses the 10% threshold | CF |
| 03/01 | Equasens to Acquire 70% Stake in Digipharmacie | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company is one of the best yield companies with high dividend expectations.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company sustains low margins.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 138.5 times its estimated earnings per share for the ongoing year.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Ratings chart - Surperformance
Sector: Integrated Telecommunications Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +1.86% | 18.47M | - | ||
| +76.84% | 11.41B | B | ||
| -12.58% | 10.07B | B- | ||
| -17.73% | 2.95B | - | ||
| +11.22% | 2.8B | C | ||
| -19.70% | 2.44B | C+ | ||
| 0.00% | 2.22B | - | - | |
| -8.46% | 1.85B | B+ | ||
| -7.20% | 1.25B | - | ||
| -7.01% | 500M | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- ALHF Stock
- Ratings HF Company
